Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.380
+0.280 (6.83%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Prelude Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Prelude Therapeutics stock have an average target of 7.67, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 75.11% from the current stock price of 4.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 4, 2026.
Analyst Ratings
The average analyst rating for Prelude Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Buy Initiates $9 | Buy | Initiates | $9 | +105.48% | May 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 → $8 | Buy | Reiterates | $5 → $8 | +82.65% | Apr 27, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $3 → $6 | Buy | Maintains | $3 → $6 | +36.99% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
37.92M
from 12.14M
Increased by 212.36%
Revenue Next Year
53.33M
from 37.92M
Increased by 40.65%
EPS This Year
-0.95
from -1.29
EPS Next Year
-0.94
from -0.95
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 104.6M | 100.0M | |
| Avg | 37.9M | 53.3M | |
| Low | 4.6M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 761.6% | 163.7% | |
| Avg | 212.4% | 40.6% | |
| Low | -62.3% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.95 | -0.94 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.